MERRIMACK PHARMACEUTICALS IN
(590328209)
Fondsberichterstattung Bestände von MERRIMACK PHARMACEUTICALS IN gemäß 13F Anmeldungen
| Firmenname | Gehaltene Aktien / Nennbetrag | Marktwert | Möglichkeit | Berichtszeitraum | Gültigkeitsdatum |
|---|---|---|---|---|---|
| 22NW LP | 1,241,896 | $7,513k | Jun 30, 2019 | Aug 14, 2019 | |
| Newtyn Management LLC | 1,212,144 | $7,333k | Jun 30, 2019 | Aug 14, 2019 | |
| Nantahala Capital Management LLC | 647,635 | $3,918k | Jun 30, 2019 | Aug 14, 2019 | |
| Western Standard LLC | 624,756 | $3,780k | Jun 30, 2019 | Aug 14, 2019 | |
| Yakira Capital Management Inc | 66,934 | $405k | Jun 30, 2019 | Aug 9, 2019 | |
| Prelude Capital Management LLC | 9,600 | $58k | Jun 30, 2019 | Aug 14, 2019 |